Successful treatment of relapsed Ménière's disease using selective serotonin reuptake inhibitors: A report of three cases
- Authors:
- Fumiyuki Goto
- Tomoko Tsutsumi
- Kaoru Ogawa
View Affiliations
Affiliations: Department of Otorhinolaryngology, National Hospital Organization, Tokyo Medical Center, Tokyo 152-0021, Japan, Department of Otorhinolaryngology, Hino Municipal Hospital, Tokyo 191-0062, Japan, Department of Otorhinolaryngology, Keio University, Tokyo 160-8520, Japan
- Published online on: November 15, 2013 https://doi.org/10.3892/etm.2013.1412
-
Pages:
488-490
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Patients with Ménière's disease who have relapsed following endolymphatic sac surgery (EDS) or intratympanic gentamicin injection are occasionally treated with intratympanic gentamicin injections or revision surgery. However, there is a potential link between Ménière's disease and anxiety or depression. The use of serotonin selective reuptake inhibitors (SSRIs) is likely be beneficial in the treatment of patients with Ménière's disease. The aim of this report is to describe the benefits of SSRIs in patients with relapsed Meniere's disease. Over the course of two years, three patients were treated for symptoms associated with Ménière's disease with an SSRI (sertraline), with the complete resolution, or significant improvement, of symptoms. In these cases, the SSRI may have treated the associated morbidity and not Ménière's disease itself. Ménière's disease that appears to be resistant to typical otological treatment may not be just Ménière's disease. Ménière's disease may co-exist with three other conditions that are able to cause vestibular symptoms and respond to SSRIs: migraine-associated vertigo (MAV), panic disorders and chronic subjective dizziness (CSD).
View References
1
|
Gouveris H, Lange G and Mann WJ:
Intratympanic gentamicin treatment after endolymphatic sac surgery.
Acta Otolaryngol. 125:1180–1183. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wetmore SJ: Endolymphatic sac surgery for
Meniere’s disease: long-term results after primary and revision
surgery. Arch Otolaryngol Head Neck Surg. 134:1144–1148. 2008.
|
3
|
Overton M: Meniere’s disease: some
patients benefit significantly from SSRIs. Aust Fam Physician.
32:82003.
|
4
|
Kitahara T, Maekawa C, Kizawa K, et al:
Plasma vasopressin and V2 receptor in the endolymphatic sac in
patients with delayed endolymphatic hydrops. Otol Neurotol.
30:812–819. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hayashi K, Kobayashi R, Kitamura K, et al:
A novel model for prognosis of Meniere’s disease using oxidative
stress susceptibility of lymphoblastoid cell lines. Biosci Trends.
4:72–78. 2010.PubMed/NCBI
|
6
|
American Academy of Otolaryngology - Head
and Neck Surgery Committee on Hearing and Equilibrium. Committee on
Hearing and Equilibrium guidelines for the diagnosis and evaluation
of therapy in Meniere’s disease. Otolaryngol Head Neck Surg.
113:181–185. 1995.
|
7
|
Staab JP and Ruckenstein MJ: Which comes
first? Psychogenic dizziness versus otogenic anxiety. Laryngoscope.
113:1714–1718. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Neuhauser H, Leopold M, von Brevern M,
Arnold G and Lempert T: The interrelations of migraine, vertigo,
and migrainous vertigo. Neurology. 56:436–441. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR™.
4th Edition. American Psychiatric Association; Arlington, VA:
2000
|
10
|
Boleas-Aguirre MS, Sánchez-Ferrandiz N,
Guillén-Grima F and Perez N: Long-term disability of class A
patients with Meniere’s disease after treatment with intratympanic
gentamicin. Laryngoscope. 117:1474–1481. 2007.PubMed/NCBI
|
11
|
Staab JP, Ruckenstein MJ, Solomon D and
Shepard NT: Serotonin reuptake inhibitors for dizziness with
psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 128:554–560.
2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Eklund S: Headache in Meniere’s disease.
Auris Nasus Larynx. 26:427–433. 1999.
|